Roche, the ABPI and self-regulation
01 July 2009
Ian Schofield and Peter Charlish
Please Login to read the full article.
01 July 2009
Ian Schofield and Peter Charlish
What does Roche's decision not to rejoin the ABPI mean for the future of self-regulation by the UK pharmaceutical industry? Well, in practical terms not a great deal, it seems. But the effect on the association's image – and its revenue base - could be a lot more serious.
The pharmaceutical...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Comparative efficacy should have a "formal role in drug licensing"
- Early Adcetris OK no surprise to SGEN after taking US FDA's advice
- UK medicines agency consults on consolidated medicines legislation and policy changes
- CHMP opines positively on Dificlir, hypertension and diabetes combos, but restricts Multaq
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
